Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients-Reference-Cited by-同舟云学术

Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients

Published:2019-05 Issue:5 Volume:103 Page:929-937
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Chen Kan,Sheng Jiexin,Ma Buyun,Cao Wanlu,Hernanda Pratika Y.,Liu Jiaye,Boor Patrick P.C.,Tjon Angela S.W.,Felczak Krzysztof,Sprengers Dave,Pankiewicz Krzysztof W.,Metselaar Herold J.,Ma Zhongren,Kwekkeboom Jaap,Peppelenbosch Maikel P.,Pan Qiuwei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference41 articles.

1. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.;Kim;Hepatology,2011

2. Hepatocellular carcinoma.;Hussain;Ann Oncol,2001

3. International Liver Transplantation Society consensus statement on immunosuppression in liver transplant recipients.;Charlton;Transplantation,2018

4. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.;Vivarelli;Liver Transpl,2005

5. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.;Tjon;Liver Transpl,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Organoids for Primary Liver Cancers: A Systematic Review of Current Applications in Diagnostics, Disease Modeling, and Drug Screening;JHEP Reports;2024-07

2. KASL clinical practice guidelines for management of autoimmune hepatitis 2022;Clinical and Molecular Hepatology;2023-07-01

3. Tumor Organoid Model and Its Pharmacological Applications in Tumorigenesis Prevention;Current Molecular Pharmacology;2023-06

4. Treatment of Autoimmune Hepatitis;The Korean Journal of Gastroenterology;2023-02-25

5. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?;Frontiers in Immunology;2023-02-16